Guodong Huang

Guodong Huang


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 February 2021 in International Journal of Molecular Medicine
Verified
Journal Article
Open access
PDF file
YLYunsheng Liu
Yunsheng Liu
XXXiangping Xu
Xiangping Xu
HTHan Tang
Han Tang
YPYuchen Pan
Yuchen Pan
BHBing Hu
Bing Hu
GHGuodong Huang
Guodong Huang
There is a growing evidence that Fyn kinase is upregulated in glioblastoma multiforme (GBM), where it plays a key role in tumor proliferation and invasion. In the present study, the antitumor effects of rosmarinic acid (RA), a Fyn inhibitor, were explored in human‑derived U251 and U343 glioma cell lines. These cells were treated with various concentrations of RA to determine its effects on proliferation, migration, invasion, apoptosis, and gene and protein expression levels. The CCK‑8 assay revealed that RA significantly suppressed cell viability of U251 and U343 cells. Furthermore, RA significantly reduced proliferation rates, inhibited migration and invasion, and decreased the expression levels of invasion‑related factors, such as matrix metalloproteinase (MMP)‑2 and MMP‑9. TUNEL staining revealed that RA resulted in a dose‑dependent increase of U251 and U343 cell apoptosis. In line with this finding, the expression of apoptosis suppressor protein Bcl‑2 was downregulated and that of the pro‑apoptotic proteins Bax and cleaved caspase‑3 was increased. In addition, it was revealed that the phosphatidylinositol 3‑kinase (PI3K)/Akt/nuclear factor‑κB (NF‑κB) signaling pathway was involved in RA‑induced cytotoxicity in U251 and U343 cells. Collectively, the present study suggested RA as a drug candidate for the treatment of GBM.

21 April 2019 in Phytotherapy Research
Verified
Journal Article
Closed access
PDF file
LCLei Chen
Lei Chen
YLYue‐Cheng Liu
Yue‐Cheng Liu
YZYue‐Yang Zheng
Yue‐Yang Zheng
JXJi Xu
Ji Xu
YZYuan Zhang
Yuan Zhang
WLWei‐Ping Li
Wei‐Ping Li

1 September 2021 in Neuropharmacology
Verified
Journal Article
Closed access
ZLZong-yang Li
Zong-yang Li
YZYuan Zhang
Yuan Zhang
YZYueyang Zheng
Yueyang Zheng
WLWenlan Liu
Wenlan Liu
XZXiejun Zhang
Xiejun Zhang
GHGuodong Huang
Guodong Huang

1 January 2022 in Aging and disease
Verified
Journal Article
Open access
PDF file
YLYun-Sheng Liu
Yun-Sheng Liu
HZHua-Fu Zhao
Hua-Fu Zhao
QLQian Li
Qian Li
HCHan-Wei Cui
Han-Wei Cui
GHGuodong Huang
Guodong Huang
Due to its extremely complex pathogenesis, no effective drugs to prevent, delay progression, or cure Alzheimer’s disease (AD) exist at present. The main pathological features of AD are senile plaques composed of β-amyloid, neurofibrillary tangles formed by hyperphosphorylation of the tau protein, and degeneration or loss of neurons in the brain. Many risk factors associated with the onset of AD, including gene mutations, aging, traumatic brain injury, endocrine and cardiovascular diseases, education level, and obesity. Growing evidence points to chronic stress as one of the major risk factors for AD, as it can promote the onset and development of AD-related pathologies via a mechanism that is not well known. The use of murine stress models, including restraint, social isolation, noise, and unpredictable stress, has contributed to improving our understanding of the relationship between chronic stress and AD. This review summarizes the evidence derived from murine models on the pathological features associated with AD and the related molecular mechanisms induced by chronic stress. These results not only provide a retrospective interpretation for understanding the pathogenesis of AD, but also provide a window of opportunity for more effective preventive and identifying therapeutic strategies for stress-induced AD.